Clinical Trial Update: Omalizumab in Non-atopic Asthma [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports a Phase 2/Phase 3 study of omalizumab in non-atopic asthma; the status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: King's College London | Conditions: Bronchial Asthma | Phase 2, Phase 3 | Status: UNKNOWN